Clinical Trial Update: DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing DTPACE followed by tandem autologous transplant with high-dose melphalan versus a MEL/DT-PACE hybrid regimen with DTPACE consolidation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CISPLATIN (cisplatin)
• DEXAMETHASONE (Dexamethasone)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• Melphalan (Melphalan)
• Thalidomide (thalidomide)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2011-08-03